Michael J. Rybak, PharmD, PhD, MPH

Poster(s):

• 1290 - Real-World Experience with Omadacycline for Nontuberculous Mycobacterial and Gram-Negative Infections: A Multicenter Evaluation

• 1295 - Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains

• 1297 - In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii

• 1573 - Daptomycin Resistant Enterococcus faecium: Combination Therapy Screening

• 1575 - Predictors of Negative Clinical Outcomes among Patients treated with Meropenem-Vaborbactam for Serious Gram-Negative Bacterial Infections: Impact of Delayed Appropriate Antibiotic Selection

• 1577 - Real-World, Multicenter Experience with Eravacycline for Various Infections